Introduction P|ESG Approach Impact Ambitions 43 The Ascendis Pharma Business Ethics & Compliance Program The Ascendis Pharma Compliance Program supports our efforts to maintain robust ethical standards and comply with applicable business conduct-related laws and regulations
Each serves a different purpose, allowing us to match the therapy to your specific health needs and goals
Biliary disease was numerically higher, but did not achieve statistical significance in the primary analysis (aHR 1.5, 95% CI: 0.9-2.5)
This is of particular relevance when considering benefits beyond glucose control, as the people observed in real-world studies will have typical comorbidities and concomitant treatments that may have resulted in them being excluded from RCTs [91]
Cheng, C., Tan, J., Qian, W., Zhang, L